Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy

NCT03255252 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped insufficient recruitment

Conditions

Cervical Cancer

Interventions

DRUG: Cisplatin injection
COMBINATION_PRODUCT: radiotherapy

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle